RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups

• From September 2026, RSV vaccination eligibility expands beyond the current age-based criteria to include older adults in specific clinical risk groups, requiring identification of at-risk patients in your practice
• Healthcare providers will need to review their patient populations to identify those meeting the new clinical risk group criteria for targeted RSV vaccination
• Implementation of the expanded programme will require updated systems and processes to ensure eligible patients are identified and offered vaccination appropriately

Information on the expansion of the eligibility criteria of the older adults respiratory syncytial virus (RSV) vaccination programme from 1 September 2026.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.